# Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)

> **NCT00842387** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2370 (estimated)

## Conditions studied

- Reflux
- Heartburn
- Regurgitation
- Esophagitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00842387
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 2370 (ESTIMATED)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842387, "Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00842387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*